Skip to main content

CASE REPORT article

Front. Pediatr.
Sec. Pediatric Infectious Diseases
Volume 13 - 2025 | doi: 10.3389/fped.2025.1449493
This article is part of the Research Topic Diagnosis, prevention, and treatment of infectious diseases in children View all 5 articles

Successful rivaroxaban and doxycycline therapy for Mycoplasma pneumonia with pulmonary embolism in children: A case report

Provisionally accepted
  • Dongyang People’s Hospital, Dongyang, China

The final, formatted version of the article will be published soon.

    The mortality of pulmonary embolism in children is high, and there is no standardized treatment protocol. We present a case of successful treatment of Mycoplasma pneumoniae (M pneumoniae) with pulmonary embolism in a child using rivaroxaban and doxycycline, thereby exploring a more appropriate treatment option. A 10-year-old male presented with fever, cough, and chest pain as the main symptoms. M pneumoniae polymerase chain reaction of bronchoalveolar lavage fluid was positive, and computed tomography angiography indicated pulmonary embolism. Azithromycin, doxycycline, and piperacillin-tazobactam were administered sequentially for infection control, while methylprednisolone was given to control inflammation and heparin and rivaroxaban for sequential treatment, resulting in a satisfactory recovery.

    Keywords: Mycoplasma, Pulmonary Embolism, rivaroxaban, Doxycycline, case report

    Received: 15 Jun 2024; Accepted: 24 Jan 2025.

    Copyright: © 2025 Fang and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: hemin Lu, Dongyang People’s Hospital, Dongyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.